RetinalGenix Technologies (RTGN) Profit After Tax (2020 - 2026)
RetinalGenix Technologies (RTGN) reported Profit After Tax of -$590489.0 for Q1 2026, down 0.55% on a YoY basis from -$593754.7 in Q1 2025, and up 5.24% sequentially from -$623127.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Profit After Tax (2020 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 7 years of Profit After Tax data on file, last reported at -$590489.0 in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 0.55% year-over-year to -$590489.0; the trailing twelve-month figure through Mar 2026 stood at -$2.4 million (up 11.96% YoY), and the FY2025 full-year result was -$2.4 million, up 43.79% from the prior year.
- Profit After Tax improved to -$590489.0 in Q1 2026, from -$623127.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$352143.0 in Q2 2023 to a low of -$2.5 million in Q3 2022.
- A 5-year average of -$784986.5 and a median of -$623127.0 in 2025 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax plunged 354.52% in 2022 and surged 72.63% in 2025, its largest moves.
- Tracing RTGN's Profit After Tax over 5 years: stood at -$674946.0 in 2022, then increased by 19.75% to -$541636.0 in 2023, then plunged by 60.08% to -$867027.0 in 2024, then advanced by 28.13% to -$623127.0 in 2025, then advanced by 5.24% to -$590489.0 in 2026.
- Business Quant data shows RTGN's Profit After Tax at -$590489.0 in Q1 2026, -$623127.0 in Q4 2025, and -$568791.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | -590,489.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -590,489.00 |
| Dec 31, 2025 | -623,127.00 |
| Sep 30, 2025 | -568,791.00 |
| Jun 30, 2025 | -649,418.00 |
| Mar 31, 2025 | -587,259.00 |
| Dec 31, 2024 | -867,027.00 |
| Sep 30, 2024 | -644,291.00 |
| Jun 30, 2024 | -663,633.00 |
| Mar 31, 2024 | -2.15 Mn |
| Dec 31, 2023 | -541,636.00 |
| Sep 30, 2023 | -686,467.00 |
| Jun 30, 2023 | -352,143.00 |
| Mar 31, 2023 | -510,643.00 |
| Dec 31, 2022 | -674,946.00 |
| Sep 30, 2022 | -2.50 Mn |
| Jun 30, 2022 | -359,335.00 |
| Mar 31, 2022 | -375,199.00 |
| Dec 31, 2021 | -409,738.00 |
| Sep 30, 2021 | -551,023.00 |
| Jun 30, 2021 | -534,852.00 |